Date: May 31, 2022
Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST)
In February of 2022 Minnesota became the first state in the U.S. to screen every newborn for congenital CMV. This was the first infectious disease added to the newborn screening panel which historically has only focused on inherited genetic conditions. This webinar will discuss the importance of congenital CMV universal screening and introduce how Minnesota plans to realize this goal.
Outline importance of congenital CMV
Discuss universal screening and impact on newborn healthcare
Illustrate how Minnesota plans to implement universal congenital CMV screening
Introduce congenital CMV (transmission, clinical presentation, complications of infection, diagnosis and treatment)
Discuss universal screening and impact
Discuss how MN plans to implement universal screening (timeframe for sample collection, sample type preference, acceptable test type (molecular, antigen), result turn-around-time)
Current vaccine status update
Webinars will be available for unlimited on-demand viewing after live event.